Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novartis Can Again Pursue Bigger Zolgensma Market After FDA Lifts OAV-101 Hold
Aug 03 2021
•
By
Alaric DeArment
The FDA has lifted a partial clinical hold on Novartis's intrathecal gene therapy OAV-101 • Source: Shutterstock
More from Gene Therapies
More from Advanced Therapies